KRAS and colon carcinoma: HGUE-C-1 cells were also treated in culture with cetuximab, an antibody against the extracellular domain of EGFR, since as mentioned above, this is a treatment used in advanced colon carcinoma patients and since HGUE-C-1 cells are wild type for KRAS and BRAF.